Ovid Therapeutics Inc (OVID) is near the middle in its industry group according to InvestorsObserver. OVID gets an overall rating of 40. That means it scores higher than 40 percent of stocks. Ovid Therapeutics Inc gets a 39 rank in the Biotechnology industry. Biotechnology is number 26 out of 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 40 would rank higher than 40 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Ovid Therapeutics Inc Stock Today?
Ovid Therapeutics Inc (OVID) stock is lower by -3.34% while the S&P 500 is higher by 0.66% as of 12:01 PM on Thursday, Feb 4. OVID has fallen -$0.11 from the previous closing price of $3.29 on volume of 1,234,638 shares. Over the past year the S&P 500 has risen 15.62% while OVID has fallen -20.30%. OVID lost -$1.39 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Ovid Therapeutics Inc (OVID) Stock.
